ReNeuron Group plc RNUGF
0.00 USD 0.00 (+0.00%)
At closeNov 12, 2026, 4:00 PM EST
0.0007 Day range 0.0007
0.0007 52-week range 0.0011
- YTD
- 0.00%
- 1 year
- 0.00%
News
proactiveinvestors.co.uk ReNeuron set to delist after it calls time on equity fundraising effort ReNeuron Group PLC (AIM:RENE, OTC:RNUGF) said it would delist from AIM after it called time on City fundraising efforts to focus on the ongoing administration process. In an update, the company said…
proactiveinvestors.co.uk ReNeuron says funding talks ongoing ReNeuron Group PLC (AIM:RENE, OTC:RNUGF) said it is seeking potential new investors to enable the company to trade as a going concern following an exit from administration. However, there is a…
proactiveinvestors.co.uk ReNeuron may have a future as a listed company, investors and creditors told ReNeuron Group PLC (AIM:RENE, OTC:RNUGF), the stem cell group placed into administration in March, said it is exploring an equity fundraiser to recapitalise the business. In an update, it was…
proactiveinvestors.com ReNeuron to showcase drug delivery platform at Cell2023 ReNeuron is to present in vivo data exemplifying the cellular and tissue targeting capabilities and highlighting the significant advantages of its CustomEX drug delivery platform at Cell 2023 in…
proactiveinvestors.com ReNeuron highlights exosome platform R&D progress ReNeuron said it had taken an important step forward with plans to differentiate its exosome platform by generating in vivo data highlighting its distinct organ and cellular targeting capabilities.…